Format

Send to

Choose Destination
Virology. 2010 Mar 30;399(1):65-76. doi: 10.1016/j.virol.2009.12.026. Epub 2010 Jan 15.

Development of quantitative and high-throughput assays of polyomavirus and papillomavirus DNA replication.

Author information

1
Laboratory of Molecular Virology, Institut de Recherches Cliniques de Montréal (IRCM), Montreal, Quebec, Canada; Department of Biochemistry, Université de Montréal, Montreal, Quebec, Canada.
2
Department of Biochemistry, Tufts University School of Medicine, Boston, MA, USA.
3
Laboratory of Molecular Virology, Institut de Recherches Cliniques de Montréal (IRCM), Montreal, Quebec, Canada; Department of Biochemistry, Université de Montréal, Montreal, Quebec, Canada. Electronic address: jacques.archambault@ircm.qc.ca.

Abstract

Polyoma- and papillomaviruses genome replication is initiated by the binding of large T antigen (LT) and of E1 and E2, respectively, at the viral origin (ori). Replication of an ori-containing plasmid occurs in cells transiently expressing these viral proteins and is typically quantified by Southern blotting or PCR. To facilitate the study of SV40 and HPV31 DNA replication, we developed cellular assays in which transient replication of the ori-plasmid is quantified using a firefly luciferase gene located in cis to the ori. Under optimized conditions, replication of the SV40 and HPV31 ori-plasmids resulted in a 50- and 150-fold increase in firefly luciferase levels, respectively. These results were validated using replication-defective mutants of LT, E1 and E2 and with inhibitors of DNA replication and cell-cycle progression. These quantitative and high-throughput assays should greatly facilitate the study of SV40 and HPV31 DNA replication and the identification of small-molecule inhibitors of this process.

PMID:
20079917
PMCID:
PMC3154085
DOI:
10.1016/j.virol.2009.12.026
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Elsevier Science Icon for PubMed Central
Loading ...
Support Center